Collaboration and License Agreements - License Agreement with Sanofi (Details) - Sanofi Agreement $ in Millions |
1 Months Ended | ||
|---|---|---|---|
|
Sep. 09, 2024
USD ($)
engager
|
Jun. 30, 2026
USD ($)
|
Sep. 30, 2025
USD ($)
|
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||
| Number of oncology TCEs | engager | 3 | ||
| Upfront payment | $ 100.0 | ||
| Payment made from escrow account | $ 75.0 | ||
| Maximum future development and regulatory milestone payments | 323.0 | ||
| Maximum commercial net sales-based milestone payments | $ 1,490.0 | ||
| Asset acquisition, period for execution of transaction (in years) | 2 years | ||
| Asset acquisition, milestone payment | $ 48.0 |